Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
For pilot studies, method development, or any protocol that will not consume 100mg inside a sensible in-use window, the smaller vial is the technically preferable choice rather than merely the cheaper one
Approval requires documented BMI of 30 kg/m or higher, or BMI of 27 kg/m with weight-related comorbidities such as hypertension or type 2 diabetes
For most patients this is clinically irrelevant, but if you're titrating slowly or have a history of dose-sensitive side effects, request a syringe with half-unit markings
Since 2014, Semaglutide GLP-1 injections have been FDA-approved for use as a means to supplement weight loss for those who are obese or who suffer from weight-related medical problems
